Financials Artemis Medicare Services Limited Bombay S.E.

Equities

ARTEMISMED

INE025R01021

Healthcare Facilities & Services

Market Closed - Bombay S.E. 06:00:54 2024-07-12 am EDT 5-day change 1st Jan Change
216.5 INR -0.96% Intraday chart for Artemis Medicare Services Limited +17.92% +20.34%

Valuation

Fiscal Period: March 2023 2024 2025 2026
Capitalization 1 9,107 23,076 29,666 -
Enterprise Value (EV) 1 9,107 23,076 29,666 29,666
P/E ratio 24.3 x 48.1 x 34.9 x 22.1 x
Yield - - - -
Capitalization / Revenue - 2.63 x 2.17 x 1.61 x
EV / Revenue - 2.63 x 2.17 x 1.61 x
EV / EBITDA - 22.8 x 14.5 x 9.18 x
EV / FCF - - - -
FCF Yield - - - -
Price to Book - 5.27 x - -
Nbr of stocks (in thousands) 134,119 135,861 136,916 -
Reference price 2 67.90 169.8 216.7 216.7
Announcement Date 5/5/23 5/10/24 - -
1INR in Million2INR
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: March 2023 2024 2025 2026
Net sales 1 - 8,786 13,690 18,450
EBITDA 1 - 1,011 2,050 3,230
EBIT - - - -
Operating Margin - - - -
Earnings before Tax (EBT) - 684.5 - -
Net income 1 386 491.4 850 1,330
Net margin - 5.59% 6.21% 7.21%
EPS 2 2.790 3.530 6.200 9.800
Free Cash Flow - - - -
FCF margin - - - -
FCF Conversion (EBITDA) - - - -
FCF Conversion (Net income) - - - -
Dividend per Share - - - -
Announcement Date 5/5/23 5/10/24 - -
1INR in Million2INR
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: March 2024 Q3 2024 Q4 2025 Q1
Net sales 1 2,188 2,252 2,390
EBITDA - - -
EBIT - - -
Operating Margin - - -
Earnings before Tax (EBT) - - -
Net income 1 - 141.8 150
Net margin - 6.3% 6.28%
EPS - - -
Dividend per Share - - -
Announcement Date 2/5/24 5/10/24 -
1INR in Million
Estimates

Balance Sheet Analysis

Fiscal Period: March 2023 2024 2025 2026
Net Debt - - - -
Net Cash position - - - -
Leverage (Debt/EBITDA) - - - -
Free Cash Flow - - - -
ROE (net income / shareholders' equity) - 11.5% 16% 20%
ROA (Net income/ Total Assets) - - - -
Assets 1 - - - -
Book Value Per Share - 32.20 - -
Cash Flow per Share - - - -
Capex - - - -
Capex / Sales - - - -
Announcement Date 5/5/23 5/10/24 - -
1INR in Million
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
216.7 INR
Average target price
226 INR
Spread / Average Target
+4.31%
Consensus

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Equities
  3. ARTEMISMED Stock
  4. ARTEMISMED Stock
  5. Financials Artemis Medicare Services Limited